Pravesh Khandelwal

Pravesh Khandelwal is an accomplished finance professional specializing in investor relations, with significant experience in the pharmaceuticals sector. Currently serving as VP, Head of Investor Relations at embecta since June 2022, Pravesh previously held roles at Endo Pharmaceuticals, where contributions included leading the investor relations program and achieving a top three ranking for investor relations in the pharma sector. Earlier experience includes positions as an Equity Research Associate at Deutsche Bank, where coverage spanned specialty and generic pharmaceuticals, and as a Financial Modeling Associate at Bloomberg, providing analytical solutions to major clients. Pravesh's educational background includes an MBA in Investment Management from Pace University's Lubin School of Business and a Bachelor's degree in Electrical and Electronics Engineering from Savitribai Phule Pune University.